SERAXIS
Seraxis is a private biotechnology company launched in March 2013. Incorporated in Singapore and the United States, their GMP lab is located in Germantown, Maryland. Seraxis team of scientists developed novel cell and encapsulation technologies. Their main goal is to bring a practical cell therapy for insulin-dependent diabetes to the clinic and provide a long term cure to patients that does not require the use of immuno-suppression. Their corporate structure and strategy is designed to achieve that goal as quickly as possible, while bringing maximum value to their shareholders.
SERAXIS
Social Links:
Industry:
Biotechnology Health Care
Founded:
2013-01-01
Address:
Germantown, Maryland, United States
Country:
United States
Website Url:
http://www.seraxis.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
40 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Nginx
Similar Organizations
Calimmune
Calimmune is a clinical-stage gene therapy company.
Neomorph
Neomorph is a biotechnology company.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Employees Featured
Founder
Investors List
Polaris Venture Capital
Polaris Venture Capital investment in Series C - Seraxis
Viva Ventures Biotech Fund
Viva Ventures Biotech Fund investment in Series C - Seraxis
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series C - Seraxis
JDRF T1D Fund
JDRF T1D Fund investment in Series C - Seraxis
Eli Lilly
Eli Lilly investment in Series C - Seraxis
Key Employee Changes
| Date | New article |
|---|---|
| 2022-08-30 | Seraxis Announces Appointment of Chief Medical Officer, Dr. Paul Strumph |
Official Site Inspections
http://www.seraxis.com Semrush global rank: 548.2 K Semrush visits lastest month: 86.87 K
- Host name: 156.22.212.35.bc.googleusercontent.com
- IP address: 35.212.22.156
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Seraxis"
Seraxis – Developing a cell therapy to treat insulin …
The Seraxis team of scientific and medical experts developed novel cell and encapsulation technologies. Our main goal is to bring a practical cell therapy for insulin-dependent diabetes to the clinic and provide a long-term normalization …See details»
Seraxis - Crunchbase Company Profile & Funding
Seraxis is a private biotechnology company launched in March 2013. Incorporated in Singapore and the United States, their GMP lab is located in Germantown, Maryland. Seraxis team of scientists developed novel cell and …See details»
Seraxis Company Profile 2024: Valuation, Funding
Seraxis General Information Description. Developer of a cell replacement therapy intended to treat insulin-dependent diabetes in patients. The company's therapy focuses on the production of insulin to control glucose levels, enabling diabetic …See details»
Cell therapy developer closes funding round to …
Sep 21, 2023 Seraxis plans to implant its cell therapy, dubbed SR-02, in humans who will be taking drugs to keep their bodies from rejecting a foreign substance, similar to the treatment a patient would get after receiving a full …See details»
Seraxis Company Profile - Office Locations, Competitors ... - Craft
Seraxis is a biotechnology company that uses proprietary technologies to develop SR-01, a cell replacement therapy. Its pure insulin-producing cells are micro-encapsulated through a …See details»
Seraxis, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
About Seraxis Seraxis is bringing transformative cures to the millions of people worldwide struggling with the management and life-threatening complications of T1D and insulin …See details»
Seraxis - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jun 14, 2024: Grant - Seraxis . …See details»
Seraxis - Contacts, Employees, Board Members, Advisors & Alumni
Seraxis has 4 current employee profiles, including Board Of Directors, Compensation Committee Member Jerry Baty. Jerry Baty Board Of Directors, Compensation Committee Member Carole …See details»
Seraxis Announces Closing of Second VC Tranche and Successful ...
Sep 21, 2023 Seraxis Inc., a cell therapy company developing a pancreatic organoid cure to transform the lives of patients with Type 1 and insulin-requiring Type 2 diabetes, today …See details»
Seraxis announces closing of second VC tranche and successful ...
Sep 21, 2023 “Seraxis manufactures off-the-shelf pancreatic organoids from a stem cell line that was itself derived from a human pancreatic islet”, said Seraxis CEO, Dr. William Rust. “The …See details»
Seraxis Presents Successful Results Using Synthetic Replacement ...
Apr 25, 2023 Seraxis has also developed the SeraGraft device and other tools to enable survival and function of the islet replacement therapy in immunocompetent hosts. Seraxis is a privately …See details»
Pancreatic Islet Replacement Therapy - Seraxis
[email protected]. 2 Why Seraxis 01 A path to a practical cure for Type 1 diabetes 02 03 2024 clinical POC on target “Immune-cloaked” candidate ... Seraxis Organization World-class …See details»
Seraxis Announced Closing of $40M Series C Financing Round
Germantown, MD – February 09, 2021 . Seraxis, a biotech company developing a cell replacement therapy for insulin-dependent diabetes today announced the successful closing of …See details»
Seraxis Announces Closing of Second VC Tranche and Successful ...
GERMANTOWN, Md., September 21, 2023 (Newswire.com) - Seraxis Inc., a cell therapy company developing a pancreatic organoid cure to transform the lives of patients with Type 1 …See details»
Seraxis Announces Publication of Preclinical Data for a Novel Islet ...
Oct 26, 2023 William Rust, CEO of Seraxis, will deliver a lecture at the IPITA-IXA-CTRMS Joint Congress on October 29 at 10:00 a.m. in San Diego entitled "Novel stem cell-derived islet-like …See details»
Seraxis Presents Successful Results Using Synthetic Replacement ...
Seraxis has also developed the SeraGraft device and other tools to enable survival and function of the islet replacement therapy in immunocompetent hosts. SERAXIS is a privately held …See details»
Seraxis to Provide Oral Update on Its Pancreatic Organoid …
Sep 28, 2023 Dr. William Rust will give an oral presentation on Seraxis' proprietary technology for the production of therapeutic pancreatic organoids from pancreas-derived stem cells, as …See details»
SERAXIS Inc. announces novel method and cell line that generate …
Sep 5, 2018 SERAXIS is a privately held biotechnology company, incorporated in Singapore and the United States. Its U.S. headquarters are located in Germantown, Maryland in the heart of …See details»
Seraxis Islet Technology Aims for Practical T1D Cure
Dec 13, 2018 Seraxis is taking the promising approach of developing a cell therapy from induced pluripotent stem cells, unlike other existing efforts which focus on embryonic stem cells. New …See details»